Is QTXB or BTI a better dividend investment in 2026?

QTXB currently yields 400000.00% with a 5% 5-year dividend growth rate. BTI yields 5.38% with 5% growth. The better choice depends on your goal: QTXB offers higher current income.

What is the dividend yield difference between QTXB and BTI?

QTXB has a forward dividend yield of 400000.00% ($2.00/share annually). BTI yields 5.38% ($3.15/share annually). The yield gap is 399994.62 percentage points.

Home › Compare › QTXB vs BTI

QTXB vs BTI: Dividend Comparison 2026

QTXB yields 400000.00% · BTI yields 5.38%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 QTXB wins by $5.011119029548644e+32M in total portfolio value

INVESTMENT

TIME HORIZON10 years

QTXB

● Live price

400000.00%

Share price

$0.00

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$5.011119029548644e+32M

Annual income

$500,865,583,351,836,840,000,000,000,000,000,000,000.00

Full QTXB calculator →

BTI

● Live price

5.38%

Share price

$58.47

Annual div

$3.15

5Y div CAGR

11.3%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$37.7K

Annual income

$2,786.64

Full BTI calculator →

Portfolio growth — QTXB vs BTI

📍 QTXB pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	QTXB	BTI
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, QTXB + BTI cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

QTXB pays

BTI pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

QTXB

Annual income on $10K today (after 15% tax)

$34,000,000.00/yr

After 10yr DRIP, annual income (after tax)

$425,735,745,849,061,300,000,000,000,000,000,000,000.00/yr

BTI

Annual income on $10K today (after 15% tax)

$457.40/yr

After 10yr DRIP, annual income (after tax)

$2,368.64/yr

At 15% tax rate, QTXB beats the other by $425,735,745,849,061,300,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of QTXB + BTI for your $10,000?

QTXB: 50%BTI: 50%

100% BTI50/50100% QTXB

Portfolio after 10yr

$2.505559514774322e+32M

Annual income

$250,432,791,675,918,420,000,000,000,000,000,000,000.00/yr

Blended yield

99.95%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on BTI right now

QTXB

No analyst data

Altman Z

-14333.8

Piotroski

1/9

BTI

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$40.00

-31.6% upside vs current

Range: $40.00 — $40.00

Altman Z

2.1

Piotroski

7/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

QTXB buys

BTI buys

No recent congressional trades found for QTXB or BTI in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricQTXBBTI

Forward yield	400000.00% ✓	5.38%
Annual dividend / share	$2.00	$3.15 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	11.3% ✓
Portfolio after 10y	$5.011119029548644e+32M	$37.7K ✓
Annual income after 10y	$500,865,583,351,836,840,000,000,000,000,000,000,000.00 ✓	$2,786.64
Total dividends collected	$5.010957816668433e+32M	$14.3K ✓
Payment frequency	quarterly	quarterly
Sector	Stock	Consumer Staples

Year-by-year: QTXB vs BTI ($10,000, DRIP)

Year	QTXB Portfolio	QTXB Income/yr	BTI Portfolio	BTI Income/yr	Gap
1← crossover	$40,010,700	$40,000,000.00	$11,299	$598.92	+$40.00M → QTXB
2	$149,615,521,729	$149,572,710,280.37	$12,794	$703.91	+$149615.51M → QTXB
3	$522,880,052,725,200	$522,719,964,116,949.25	$14,518	$829.07	+$522880052.71M → QTXB
4	$1,707,862,989,289,045,000	$1,707,303,507,632,628,700.00	$16,513	$978.64	+$1707862989289.03M → QTXB
5	$5,213,509,402,845,684,000,000	$5,211,681,989,447,144,000,000.00	$18,827	$1,157.84	+$5213509402845684.00M → QTXB
6	$14,874,219,058,409,543,000,000,000	$14,868,640,603,348,497,000,000,000.00	$21,518	$1,373.12	+$14874219058409543680.00M → QTXB
7	$39,661,196,234,050,755,000,000,000,000	$39,645,280,819,658,260,000,000,000,000.00	$24,657	$1,632.46	+$3.966119623405075e+22M → QTXB
8	$98,838,436,350,327,300,000,000,000,000,000	$98,795,998,870,356,880,000,000,000,000,000.00	$28,329	$1,945.74	+$9.88384363503273e+25M → QTXB
9	$230,205,236,474,344,900,000,000,000,000,000,000	$230,099,479,347,450,050,000,000,000,000,000,000.00	$32,637	$2,325.33	+$2.302052364743449e+29M → QTXB
10	$501,111,902,954,864,400,000,000,000,000,000,000,000	$500,865,583,351,836,840,000,000,000,000,000,000,000.00	$37,708	$2,786.64	+$5.011119029548644e+32M → QTXB

QTXB vs BTI: Complete Analysis 2026

QTXB — Stock

QuantRx Biomedical Corporation engages in the development and commercialization of patented miniform pads (PADs) and PAD based over-the-counter products in the United States. It is also developing genomic diagnostics for the laboratory market based on its lateral flow patents, including RapidSense technology, a one-step lateral flow test. The company's PAD products are used for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses, and other medical needs. Its products include InSync, a feminine hygienic interlabial pad; Unique miniform, a treated pad for the temporary relief of the itch and discomfort associated with hemorrhoids and minor vaginal infection, as well as an untreated pad for the daily protection of light urinary, vaginal, or anal leakage; and other treated miniform products. QuantRx Biomedical Corporation was incorporated in 1986 and is based in Tualatin, Oregon.

Full QTXB Calculator →

BTI — Consumer Staples

British American Tobacco p.l.c. provides tobacco and nicotine products to consumers in the Americas, Europe, the Asia-Pacific, the Middle East, Africa, and the United States. It offers vapour, heated, and modern oral nicotine products; combustible cigarettes; and traditional oral products, such as snus and moist snuff. The company provides its products under the Vuse, glo, Velo, Grizzly, Kodiak, Dunhill, Kent, Lucky Strike, Pall Mall, Rothmans, Newport, Natural American Spirit, and Camel brands. The company distributes its products to retail outlets. British American Tobacco p.l.c. was founded in 1902 and is based in London, the United Kingdom.

Full BTI Calculator →

📬

Get this QTXB vs BTI comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

QTXB vs SCHD QTXB vs JEPI QTXB vs O QTXB vs KO QTXB vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.